RxDoctor Payments Data

Kaylee Mondrick

Psychiatric/Mental Health · Clinton, LANPI 1972249175

Payments from drug & device makers

$3,359in general payments, 2019–2025

Across 214 payments — averaging $15.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$782
  • AbbVie$700
  • Corium, LLC$674
  • Axsome Therapeutics, Inc.$272
  • Alkermes, Inc.$262
  • Otsuka America Pharmaceutical, Inc.$186
  • plus $483 from 9 others

What the payments were for

  • Food & beverage$3,359100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,359 in reported general payments places this provider in the 75th percentile of 615 psychiatric/mental health providers in Louisiana.

See all psychiatric/mental health providers in Louisiana

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate12$100,968
VraylarCariprazine Hcl12$17,478
Olanzapine70$1,169
Quetiapine Fumarate77$1,163
Bupropion XlBupropion Hcl60$1,059
Buspirone Hcl53$920
Hydroxyzine Hcl18$772
Mirtazapine68$764
Trazodone Hcl42$735
Duloxetine Hcl33$538
Prazosin Hcl49$443
Oxcarbazepine16$411
Desvenlafaxine Succinate ErDesvenlafaxine Succinate11$396
Escitalopram Oxalate28$252
Sertraline Hcl61$210

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Neurocrine Biosciences, Inc.Ingrezza$55$100,96812 claims
AbbVieVraylar$700$17,47812 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 615 psychiatric/mental health providers in Louisiana.

Other psychiatric/mental health in Clinton

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →